Disease management protocols, therapies, clinical research updates and more, on audio clips with slides for medical education on the go.

  • Individualizing Symptomatic Therapies for Alzheimer’s Disease

    Alzheimer’s disease expert Richard S. Isaacson, MD, explores strategies for care collaboration to optimize care for patients with Alzheimer’s disease (AD), the importance of determining patient-specific pharmacologic treatment approaches for patients with AD, and implementing approaches for effective communication with patients and caregivers surrounding AD diagnosis and management.

  • Atopic Dermatitis: Important Advances in JAK Treatments

    Dermatology expert Linda Stein Gold, MD, explores the rationale for Janus kinase (JAK) inhibition in atopic dermatitis (AD), clinical trial data on approved and emerging JAK inhibitors in this setting, and the importance of considering JAK inhibitors when creating patient-specific plans for patients with inadequately controlled AD.

  • Navigating Recent Advances in Alzheimer’s Disease: Expert Insights on Neuropathological Diagnostic Markers and the Clinical Potential of Novel Disease-Modifying Therapies

    What role do biomarkers play in Alzheimer’s disease (AD)? The availability of a new pharmacologic class for AD offers the potential for disease modification when added early in the disease course, emphasizing the importance of novel biomarkers. In this podcast, experts review the association between biomarkers and symptoms of AD, the use of biomarkers for the early detection of AD, and the potential of available and emerging disease-modifying therapies for AD.

  • Advancing the Discussion and Management of Vasomotor Symptoms Associated With Menopause

    Join experts to learn more about vasomotor symptoms of menopause – contributing factors, undertreatment, current treatment options, and emerging therapies with novel targets.

  • Dry Eye Disease and Meibomian Gland Dysfunction: Early Diagnosis and Comprehensive Management

    Are you aware of the strong association between dry eye disease (DED) and meibomian gland dysfunction (MGD)? Recent evidence demonstrates that DED is most often associated with MGD. Moreover, many risk factors, signs, and symptoms overlap, which complicates patient care. Join Eric D. Donnenfeld, MD, in this 30-minute educational podcast as he offers valuable insights on this association, as well as the evidence-based protocol for assessment, diagnosis, and proper disease management.